COMMUNIQUÉS West-GlobeNewswire

Alpha Pro Tech, LTD. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2017
08/03/2018
Net income for 2017 was $2.6 million, or $0.18 per diluted share, compared to $3.2 million, or $0.19 per diluted share, for 2016 Excluding a $619,000 accrual related to the death of our former President and Chairman, [...]
Albert White to Succeed Robert Weiss as CEO of the Cooper Companies
08/03/2018
PLEASANTON, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced that its Board of Directors has named Albert G. White III President and Chief Executive Officer of The [...]
INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results
08/03/2018
PHOENIX, March 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reported [...]
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
- On track to begin first company-sponsored clinical trials of a CRISPR-based therapy - - Wholly-owned CRISPR-based allogeneic CAR-T programs advancing rapidly - ZUG, Switzerland and CAMBRIDGE, Mass., March 08, 2018 ( [...]
Clearside Biomedical to Present at the Cowen and Company 38th Annual Health Care Conference
08/03/2018
ALPHARETTA, Ga., March 08, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]
Calithera Biosciences Reports Fourth Quarter 2017 Financial Results and Recent Highlights
08/03/2018
SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA ), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs [...]
The Joint Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
29% Annual System-Wide Gross Sales Increase to $126.9 Million for 2017 23% Annual Revenue Growth to $25.2 Million for 2017 $11.9 Million Improvement in Net Loss to $(3.3) Million for 2017 $7.6 Million, or 99%, [...]
Codexis Reports 2017 Fourth Quarter and Full Year Financial Results
08/03/2018
2017 revenues of $50 million include a 74% increase in product sales Introduces 2018 financial guidance Conference call begins at 4:30 pm Eastern time today Accompanying slide presentation available on Investor section [...]
MediWound to Present at Two Investor Conferences
08/03/2018
YAVNE, Israel, March 08, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
IRIDEX Announces 2017 Fourth Quarter and Full Year Financial Results
08/03/2018
MOUNTAIN VIEW, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and full year ended December 30, 2017. Fourth Quarter Highlights Fourth [...]
Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2017 Financial Results
08/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced that the company will report financial results for the three months ended December 31, 2018, before the opening of trading [...]
Caladrius Biosciences to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium
08/03/2018
BASKING RIDGE, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/03/2018
MENLO PARK, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new [...]
Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
MEDFORD, N.Y., March 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care ("POC") diagnostic tests for infectious diseases, today reported financial results for the fourth [...]
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Highlights
08/03/2018
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today reported financial results for the fourth [...]
Yield10 Bioscience Announces Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
WOBURN, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]
MyoKardia Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
Announced Achievement of Primary Endpoint and Additional Key Data from Low-Dose Mavacamten Cohort of PIONEER-HCM Phase 2 Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Company to Host Conference Call and [...]
MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients
08/03/2018
Met Primary Endpoint and Key Secondary Endpoints with Statistical Significance Study Results Inform Phase 3 EXPLORER-HCM Dosing; First Patient Planned for Q2 2018 Conference Call Today at 4:30 p.m. ET (1:30 p.m. PT); [...]
Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
08/03/2018
MORRISTOWN, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, announced today financial results for the three and twelve months ended [...]

Pages